Literature DB >> 17111889

Otitis externa: Review and clinical update.

J David Osguthorpe1, David R Nielsen.   

Abstract

Otitis externa can take an acute or a chronic form, with the acute form affecting four in 1,000 persons annually and the chronic form affecting 3 to 5 percent of the population. Acute disease commonly results from bacterial (90 percent of cases) or fungal (10 percent of cases) overgrowth in an ear canal subjected to excess moisture or to local trauma. Chronic disease often is part of a more generalized dermatologic or allergic problem. Symptoms of early acute and most chronic disease include pruritus and local discomfort. If left untreated, acute disease can be followed by canal edema, discharge, and pain, and eventually by extra-canal manifestations. Topical application of an acidifying solution is usually adequate in treating early disease. An antimicrobial-containing ototopical is the preferred treatment for later-stage acute disease, and oral antibiotic therapy is reserved for advanced disease or those who are immunocompromised. Preventive measures reduce recurrences and typically involve minimizing ear canal moisture, trauma, or exposure to materials that incite local irritation or contact dermatitis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17111889

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  19 in total

1.  Otitis externa: quality of life assessment.

Authors:  R Ali; P Burns; M Donnelly
Journal:  Ir J Med Sci       Date:  2008-02-23       Impact factor: 1.568

2.  Acute otitis externa.

Authors:  Charles Ps Hui
Journal:  Paediatr Child Health       Date:  2013-02       Impact factor: 2.253

3.  Role of pH of External Auditory Canal in Acute Otitis Externa.

Authors:  Aayush Mittal; Sunil Kumar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2013-10-24

4.  The management of otitis externa in UK general practice.

Authors:  L Pabla; M Jindal; K Latif
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-07-15       Impact factor: 2.503

5.  Antimicrobial effects of Burow's solution on Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Yukiyoshi Hyo; Sakuo Yamada; Masaki Ishimatsu; Kenji Fukutsuji; Tamotsu Harada
Journal:  Med Mol Morphol       Date:  2012-06-21       Impact factor: 2.309

6.  Clinical Differences in Types of Otalgia.

Authors:  Sang Hoon Kim; Tae Hyun Kim; Jae Yong Byun; Moon Suh Park; Seung Geun Yeo
Journal:  J Audiol Otol       Date:  2015-04-17

7.  Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection.

Authors:  Assaf Raz; Anna Serrano; Anaise Hernandez; Chad W Euler; Vincent A Fischetti
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

8. 

Authors:  María José Monedero Mira; Manuel Batalla Sales; Concepción García Domingo; María José Monedero Mira; Belén Persiva Saura; Gloria Rabanaque Mallen; Lledó Tárrega Porcar
Journal:  FMC       Date:  2016-04-26

9.  [Topical immunomodulation. A milestone for the treatment of therapy-resistant noninfectious chronic external otitis?].

Authors:  P P Caffier; W Harth; B Mayelzadeh; H Haupt; H Scherer; B Sedlmaier
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

10.  Is pimecrolimus cream (1%) an appropriate therapeutic agent for the treatment of external ear atopic dermatitis?

Authors:  Güçlü Kaan Beriat; Sefik Halit Akmansu; Cem Doğan; Eren Taştan; Ferda Topal; Bizden Sabuncuoğlu
Journal:  Med Sci Monit       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.